AstraZeneca Plc will invest $360 million building a new manufacturing facility for small molecules in Dublin, in a blow to U.K. hopes that the drugmaker would develop the site in its domestic market. ...
Source LinkBloomberg2021-09-21
AstraZeneca Plc will invest $360 million building a new manufacturing facility for small molecules in Dublin, in a blow to U.K. hopes that the drugmaker would develop the site in its domestic market. ...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Terms and Conditions·Privacy Policy
Company: TTMF Limited. Tech supported by Xiangshang Yixin.
Email:uservice@ttm.financial